IL1R1 and chronic obstructive pulmonary disease: This clinical study raises the possibility that patients with COPD and high neutrophil counts may benefit from inhibition of IL-1R1; however, baseline serum CRP or fibrinogen concentrations may not be suitable biomarkers to identify this population.